Section Arrow
IVF.NASDAQ
- INVO Fertility Inc
Quotes are at least 15-min delayed:2025/12/04 03:50 EST
Pre Market
Last
 --
-- (--)
Bid
--
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 1.6
+0.11 (+7.38%)
Day High 
1.6 
Prev. Close
1.49 
1-M High
4.9 
Volume 
543.46K 
Bid
--
Ask
--
Day Low
1.32 
Open
1.4 
1-M Low
1.41 
Market Cap 
22.54M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.36 
20-SMA 3.24 
50-SMA 4.8 
52-W High 299.52 
52-W Low 1.41 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2,184.88/-3.24
Enterprise Value
25.86M
Balance Sheet
Book Value Per Share
-0.20
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.53M
Operating Revenue Per Share
0.37
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc0.1902+0.0152+8.69%-- 
Pre Market -- -- --
BSXBoston Scientific Corp98.57-0.45-0.45%52.95PE
Pre Market -- -- --
LFWDLifeward Ltd0.69+0.14+25.45%-- 
Pre Market -- -- --
PACBPacific Biosciences of California2.43+0.11+4.74%-- 
Pre Market -- -- --
BFLYButterfly Network2.97+0.23+8.39%-- 
Pre Market -- -- --
Industry overview quotes are at least 15 minutes delayed
Business Description
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic; The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell; and The Therapeuticssegment consisting of financial information relating to acquired subsidiary, NTI.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.